Asklepios Hospital Barmbek
Asklepios Hospital Barmbek holds the No. 1 ranking for foreign patients by the Medical Travel Quality Alliance. The hospital offers immunotherapy with Keytruda (Pembrolizumab) within its advanced oncology department. The facility treats 80,000 patients annually, ensuring high standards and safety with a DIN EN ISO 9001: 2015 certification. The multidisciplinary team approach ensures precise treatment plans. Located 8 km from Hamburg's central square, patients can explore nearby attractions during their stay.